English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 115 | Tables: 121 | Pharma & Healthcare
The global market for Natamycin was estimated to be worth US$ 210 million in 2024 and is forecast to a readjusted size of US$ 323 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
This report aims to provide a comprehensive presentation of the global market for Natamycin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Natamycin by region & country, by Type, and by Application.
The Natamycin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natamycin.
Market Segmentation
By Company
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Segment by Type
Glucose-based
Lactose-based
Sodium chloride-based
Segment by Application
Food
Medical
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Natamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Natamycin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Natamycin Product Introduction
1.2 Global Natamycin Market Size Forecast
1.2.1 Global Natamycin Sales Value (2020-2031)
1.2.2 Global Natamycin Sales Volume (2020-2031)
1.2.3 Global Natamycin Sales Price (2020-2031)
1.3 Natamycin Market Trends & Drivers
1.3.1 Natamycin Industry Trends
1.3.2 Natamycin Market Drivers & Opportunity
1.3.3 Natamycin Market Challenges
1.3.4 Natamycin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Natamycin Players Revenue Ranking (2024)
2.2 Global Natamycin Revenue by Company (2020-2025)
2.3 Global Natamycin Players Sales Volume Ranking (2024)
2.4 Global Natamycin Sales Volume by Company Players (2020-2025)
2.5 Global Natamycin Average Price by Company (2020-2025)
2.6 Key Manufacturers Natamycin Manufacturing Base and Headquarters
2.7 Key Manufacturers Natamycin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Natamycin
2.9 Natamycin Market Competitive Analysis
2.9.1 Natamycin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Natamycin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Glucose-based
3.1.2 Lactose-based
3.1.3 Sodium chloride-based
3.2 Global Natamycin Sales Value by Type
3.2.1 Global Natamycin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Natamycin Sales Value, by Type (2020-2031)
3.2.3 Global Natamycin Sales Value, by Type (%) (2020-2031)
3.3 Global Natamycin Sales Volume by Type
3.3.1 Global Natamycin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Natamycin Sales Volume, by Type (2020-2031)
3.3.3 Global Natamycin Sales Volume, by Type (%) (2020-2031)
3.4 Global Natamycin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food
4.1.2 Medical
4.1.3 Others
4.2 Global Natamycin Sales Value by Application
4.2.1 Global Natamycin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Natamycin Sales Value, by Application (2020-2031)
4.2.3 Global Natamycin Sales Value, by Application (%) (2020-2031)
4.3 Global Natamycin Sales Volume by Application
4.3.1 Global Natamycin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Natamycin Sales Volume, by Application (2020-2031)
4.3.3 Global Natamycin Sales Volume, by Application (%) (2020-2031)
4.4 Global Natamycin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Natamycin Sales Value by Region
5.1.1 Global Natamycin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Natamycin Sales Value by Region (2020-2025)
5.1.3 Global Natamycin Sales Value by Region (2026-2031)
5.1.4 Global Natamycin Sales Value by Region (%), (2020-2031)
5.2 Global Natamycin Sales Volume by Region
5.2.1 Global Natamycin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Natamycin Sales Volume by Region (2020-2025)
5.2.3 Global Natamycin Sales Volume by Region (2026-2031)
5.2.4 Global Natamycin Sales Volume by Region (%), (2020-2031)
5.3 Global Natamycin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Natamycin Sales Value, 2020-2031
5.4.2 North America Natamycin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Natamycin Sales Value, 2020-2031
5.5.2 Europe Natamycin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Natamycin Sales Value, 2020-2031
5.6.2 Asia Pacific Natamycin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Natamycin Sales Value, 2020-2031
5.7.2 South America Natamycin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Natamycin Sales Value, 2020-2031
5.8.2 Middle East & Africa Natamycin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Natamycin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Natamycin Sales Value
6.2.1 Key Countries/Regions Natamycin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Natamycin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Natamycin Sales Value, 2020-2031
6.3.2 United States Natamycin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Natamycin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Natamycin Sales Value, 2020-2031
6.4.2 Europe Natamycin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Natamycin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Natamycin Sales Value, 2020-2031
6.5.2 China Natamycin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Natamycin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Natamycin Sales Value, 2020-2031
6.6.2 Japan Natamycin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Natamycin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Natamycin Sales Value, 2020-2031
6.7.2 South Korea Natamycin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Natamycin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Natamycin Sales Value, 2020-2031
6.8.2 Southeast Asia Natamycin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Natamycin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Natamycin Sales Value, 2020-2031
6.9.2 India Natamycin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Natamycin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Danisco
7.1.1 Danisco Company Information
7.1.2 Danisco Introduction and Business Overview
7.1.3 Danisco Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Danisco Natamycin Product Offerings
7.1.5 Danisco Recent Development
7.2 DSM
7.2.1 DSM Company Information
7.2.2 DSM Introduction and Business Overview
7.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 DSM Natamycin Product Offerings
7.2.5 DSM Recent Development
7.3 VGP
7.3.1 VGP Company Information
7.3.2 VGP Introduction and Business Overview
7.3.3 VGP Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 VGP Natamycin Product Offerings
7.3.5 VGP Recent Development
7.4 Handary
7.4.1 Handary Company Information
7.4.2 Handary Introduction and Business Overview
7.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Handary Natamycin Product Offerings
7.4.5 Handary Recent Development
7.5 AMTECH BIOTECH
7.5.1 AMTECH BIOTECH Company Information
7.5.2 AMTECH BIOTECH Introduction and Business Overview
7.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 AMTECH BIOTECH Natamycin Product Offerings
7.5.5 AMTECH BIOTECH Recent Development
7.6 Silver-Elephant
7.6.1 Silver-Elephant Company Information
7.6.2 Silver-Elephant Introduction and Business Overview
7.6.3 Silver-Elephant Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Silver-Elephant Natamycin Product Offerings
7.6.5 Silver-Elephant Recent Development
7.7 Lanzhou Weiri
7.7.1 Lanzhou Weiri Company Information
7.7.2 Lanzhou Weiri Introduction and Business Overview
7.7.3 Lanzhou Weiri Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Lanzhou Weiri Natamycin Product Offerings
7.7.5 Lanzhou Weiri Recent Development
7.8 Langfang Meihua
7.8.1 Langfang Meihua Company Information
7.8.2 Langfang Meihua Introduction and Business Overview
7.8.3 Langfang Meihua Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Langfang Meihua Natamycin Product Offerings
7.8.5 Langfang Meihua Recent Development
7.9 Zhengzhou New Frey
7.9.1 Zhengzhou New Frey Company Information
7.9.2 Zhengzhou New Frey Introduction and Business Overview
7.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Zhengzhou New Frey Natamycin Product Offerings
7.9.5 Zhengzhou New Frey Recent Development
7.10 Chihon
7.10.1 Chihon Company Information
7.10.2 Chihon Introduction and Business Overview
7.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Chihon Natamycin Product Offerings
7.10.5 Chihon Recent Development
7.11 Jiaozuo Joincare
7.11.1 Jiaozuo Joincare Company Information
7.11.2 Jiaozuo Joincare Introduction and Business Overview
7.11.3 Jiaozuo Joincare Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Jiaozuo Joincare Natamycin Product Offerings
7.11.5 Jiaozuo Joincare Recent Development
7.12 Beijing Oriental Rada
7.12.1 Beijing Oriental Rada Company Information
7.12.2 Beijing Oriental Rada Introduction and Business Overview
7.12.3 Beijing Oriental Rada Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Beijing Oriental Rada Natamycin Product Offerings
7.12.5 Beijing Oriental Rada Recent Development
7.13 Pucheng Lifecome
7.13.1 Pucheng Lifecome Company Information
7.13.2 Pucheng Lifecome Introduction and Business Overview
7.13.3 Pucheng Lifecome Natamycin Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Pucheng Lifecome Natamycin Product Offerings
7.13.5 Pucheng Lifecome Recent Development
8 Industry Chain Analysis
8.1 Natamycin Industrial Chain
8.2 Natamycin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Natamycin Sales Model
8.5.2 Sales Channel
8.5.3 Natamycin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Natamycin Market Trends
Table 2. Natamycin Market Drivers & Opportunity
Table 3. Natamycin Market Challenges
Table 4. Natamycin Market Restraints
Table 5. Global Natamycin Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Natamycin Revenue Market Share by Company (2020-2025)
Table 7. Global Natamycin Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Natamycin Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Natamycin Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Natamycin Manufacturing Base and Headquarters
Table 11. Key Manufacturers Natamycin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Natamycin
Table 13. Global Natamycin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Natamycin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Natamycin Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Natamycin Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Natamycin Sales Market Share in Value by Type (2020-2025)
Table 20. Global Natamycin Sales Market Share in Value by Type (2026-2031)
Table 21. Global Natamycin Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Natamycin Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Natamycin Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Natamycin Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Natamycin Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Natamycin Price by Type (2020-2025) & (USD/MT)
Table 27. Global Natamycin Price by Type (2026-2031) & (USD/MT)
Table 28. Global Natamycin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Natamycin Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Natamycin Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Natamycin Sales Market Share in Value by Application (2020-2025)
Table 32. Global Natamycin Sales Market Share in Value by Application (2026-2031)
Table 33. Global Natamycin Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Natamycin Sales Volume by Application (2020-2025) & (MT)
Table 35. Global Natamycin Sales Volume by Application (2026-2031) & (MT)
Table 36. Global Natamycin Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Natamycin Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Natamycin Price by Application (2020-2025) & (USD/MT)
Table 39. Global Natamycin Price by Application (2026-2031) & (USD/MT)
Table 40. Global Natamycin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Natamycin Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Natamycin Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Natamycin Sales Value by Region (2020-2025) & (%)
Table 44. Global Natamycin Sales Value by Region (2026-2031) & (%)
Table 45. Global Natamycin Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 46. Global Natamycin Sales Volume by Region (2020-2025) & (MT)
Table 47. Global Natamycin Sales Volume by Region (2026-2031) & (MT)
Table 48. Global Natamycin Sales Volume by Region (2020-2025) & (%)
Table 49. Global Natamycin Sales Volume by Region (2026-2031) & (%)
Table 50. Global Natamycin Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Natamycin Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Natamycin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Natamycin Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Natamycin Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Natamycin Sales Volume, (2020-2025) & (MT)
Table 56. Key Countries/Regions Natamycin Sales Volume, (2026-2031) & (MT)
Table 57. Danisco Company Information
Table 58. Danisco Introduction and Business Overview
Table 59. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Danisco Natamycin Product Offerings
Table 61. Danisco Recent Development
Table 62. DSM Company Information
Table 63. DSM Introduction and Business Overview
Table 64. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. DSM Natamycin Product Offerings
Table 66. DSM Recent Development
Table 67. VGP Company Information
Table 68. VGP Introduction and Business Overview
Table 69. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. VGP Natamycin Product Offerings
Table 71. VGP Recent Development
Table 72. Handary Company Information
Table 73. Handary Introduction and Business Overview
Table 74. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Handary Natamycin Product Offerings
Table 76. Handary Recent Development
Table 77. AMTECH BIOTECH Company Information
Table 78. AMTECH BIOTECH Introduction and Business Overview
Table 79. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. AMTECH BIOTECH Natamycin Product Offerings
Table 81. AMTECH BIOTECH Recent Development
Table 82. Silver-Elephant Company Information
Table 83. Silver-Elephant Introduction and Business Overview
Table 84. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Silver-Elephant Natamycin Product Offerings
Table 86. Silver-Elephant Recent Development
Table 87. Lanzhou Weiri Company Information
Table 88. Lanzhou Weiri Introduction and Business Overview
Table 89. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Lanzhou Weiri Natamycin Product Offerings
Table 91. Lanzhou Weiri Recent Development
Table 92. Langfang Meihua Company Information
Table 93. Langfang Meihua Introduction and Business Overview
Table 94. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Langfang Meihua Natamycin Product Offerings
Table 96. Langfang Meihua Recent Development
Table 97. Zhengzhou New Frey Company Information
Table 98. Zhengzhou New Frey Introduction and Business Overview
Table 99. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Zhengzhou New Frey Natamycin Product Offerings
Table 101. Zhengzhou New Frey Recent Development
Table 102. Chihon Company Information
Table 103. Chihon Introduction and Business Overview
Table 104. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Chihon Natamycin Product Offerings
Table 106. Chihon Recent Development
Table 107. Jiaozuo Joincare Company Information
Table 108. Jiaozuo Joincare Introduction and Business Overview
Table 109. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Jiaozuo Joincare Natamycin Product Offerings
Table 111. Jiaozuo Joincare Recent Development
Table 112. Beijing Oriental Rada Company Information
Table 113. Beijing Oriental Rada Introduction and Business Overview
Table 114. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Beijing Oriental Rada Natamycin Product Offerings
Table 116. Beijing Oriental Rada Recent Development
Table 117. Pucheng Lifecome Company Information
Table 118. Pucheng Lifecome Introduction and Business Overview
Table 119. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Pucheng Lifecome Natamycin Product Offerings
Table 121. Pucheng Lifecome Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Natamycin Downstream Customers
Table 125. Natamycin Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Natamycin Product Picture
Figure 2. Global Natamycin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Natamycin Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Natamycin Sales Volume (2020-2031) & (MT)
Figure 5. Global Natamycin Sales Price (2020-2031) & (USD/MT)
Figure 6. Natamycin Report Years Considered
Figure 7. Global Natamycin Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Natamycin Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Natamycin Revenue in 2024
Figure 10. Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Glucose-based Picture
Figure 12. Lactose-based Picture
Figure 13. Sodium chloride-based Picture
Figure 14. Global Natamycin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Natamycin Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Natamycin Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 17. Global Natamycin Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Natamycin Price by Type (2020-2031) & (USD/MT)
Figure 19. Product Picture of Food
Figure 20. Product Picture of Medical
Figure 21. Product Picture of Others
Figure 22. Global Natamycin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Natamycin Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Natamycin Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 25. Global Natamycin Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Natamycin Price by Application (2020-2031) & (USD/MT)
Figure 27. North America Natamycin Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Natamycin Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Natamycin Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Natamycin Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Natamycin Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Natamycin Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Natamycin Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Natamycin Sales Volume (%), (2020-2031)
Figure 39. United States Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 45. China Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 47. China Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 57. India Natamycin Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Natamycin Sales Value by Type (%), 2024 VS 2031
Figure 59. India Natamycin Sales Value by Application (%), 2024 VS 2031
Figure 60. Natamycin Industrial Chain
Figure 61. Natamycin Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
